Academic literature on the topic 'Cellules MIAMI'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cellules MIAMI.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cellules MIAMI"

1

Li, Ye, Wenjing Wang, Xiaoxue Xu, Shiyue Sun, Xiaoyu Xu, and Xian-jun Qu. "{2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic Acid Methyl Ester Inhibited Hepatocellular Carcinoma Growth in Bel-7402 Cells and Its Resistant Variants by Activation of NOX4 and SIRT3." BioMed Research International 2015 (2015): 1–10. http://dx.doi.org/10.1155/2015/491205.

Full text
Abstract:
{2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM) is a novel indole compound, which possessed high efficacy against many cancers xenografted in mice without obvious toxicity. In this study, we aimed to investigate the effects of MIAM on human hepatocellular carcinoma (HCC) Bel-7402 cells and its resistant variants Bel-7402/5FU. MIAM inhibited the growth of HCC more potent in Bel-7402/5FU cells than its parent cells. MIAM increased cellular reactive oxygen species (ROS) levels, induced cell apoptosis, and arrested cell cycle in G0/G1pha
APA, Harvard, Vancouver, ISO, and other styles
2

Mitsui, A., S. Cao, A. Takahashi, and T. Arai. "Growth synchrony and cellular parameters of the unicellular nitrogen-fixing marine cyanobacterium, Synechococcus sp. strain Miami BG 043511 under continuous illumination." Physiologia Plantarum 69, no. 1 (1987): 1–8. http://dx.doi.org/10.1111/j.1399-3054.1987.tb01938.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Suter, Robert, Vasileios Stathias, Anna Jermakowicz, et al. "COMP-16. COMPREHENSIVE TRANSCRIPTOMIC ANALYSIS OF SINGLE CELLS FROM RECURRENT AND PRIMARY GLIOBLASTOMA TO PREDICT CELL-TYPE SPECIFIC THERAPEUTICS." Neuro-Oncology 21, Supplement_6 (2019): vi64. http://dx.doi.org/10.1093/neuonc/noz175.259.

Full text
Abstract:
Abstract Glioblastoma (GBM) remains the most common adult brain tumor, with poor survival expectations, and no new therapeutic modalities approved in the last decade. Our laboratories have recently demonstrated that the integration of a transcriptional disease signature obtained from The Cancer Genome Atlas’ GBM dataset with transcriptional cell drug-response signatures in the LINCS L1000 dataset yields possible combinatorial therapeutics. Considering the extreme intra-tumor heterogeneity associated with the disease, we hypothesize that the utilization of single-cell RNA-sequencing (scRNA-seq)
APA, Harvard, Vancouver, ISO, and other styles
4

Farhangi, Monika, Ryan J. Diel, Dawn C. Buse, et al. "Individuals with migraine have a different dry eye symptom profile than individuals without migraine." British Journal of Ophthalmology 104, no. 2 (2019): 260–64. http://dx.doi.org/10.1136/bjophthalmol-2018-313471.

Full text
Abstract:
BackgroundMany individuals with migraine report symptoms of dry eye (DE). However, it is not known whether DE profiles are similar between individuals with and without migraine. To bridge this gap, we evaluated symptoms and signs of DE, including symptoms suggestive of nerve dysfunction, in a large group of individuals with DE symptoms, and compared profiles between individuals with migraine and those without migraine or headache.MethodsProspective cross-sectional study of individuals with DE symptoms seen at the Miami VA.ResultsOf 250 individuals, 31 met International Classification of Headac
APA, Harvard, Vancouver, ISO, and other styles
5

Gozes, Illana, and Douglas E. Brenneman. "Summer Neuropeptide Conference: The 14th Annual Meeting of the Summer Neuropeptide Conference, Miami Beach, Florida, USA, July 5–9, 2004." Neuropeptides 39, no. 1 (2005): 29–33. http://dx.doi.org/10.1016/j.npep.2004.09.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Diel, Ryan J., Jodi Hwang, Zachary A. Kroeger, et al. "Photophobia and sensations of dryness in patients with migraine occur independent of baseline tear volume and improve following botulinum toxin A injections." British Journal of Ophthalmology 103, no. 8 (2018): 1024–29. http://dx.doi.org/10.1136/bjophthalmol-2018-312649.

Full text
Abstract:
BackgroundTo evaluate the efficacy of botulinum toxin A (BoNT-A) in reducing photophobia and dry eye symptoms in individuals with chronic migraine. Additionally, we aimed to evaluate tear film volume as a potential contributor to symptoms in these patients.MethodsRetrospective review of 76 patients who received BoNT-A for chronic migraine between 23 August 2017 and 13 December 2017 at the Miami Veterans Affairs Medical Center Neurotoxin Clinic. Demographic data and all comorbidities were queried via chart review. Standardised validated surveys were administered to assess symptoms prior to and
APA, Harvard, Vancouver, ISO, and other styles
7

Bradley, Walter G. "Late effects of poliomyelitis.By L. S. Halstead, D. O. Wiechers, 236 pp, Symposia Foundation, Miami, FL, 1985. ($17.95 soft cover; $27.95 hard cover)." Muscle & Nerve 9, no. 5 (1986): 476. http://dx.doi.org/10.1002/mus.880090514.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ahmad, Sarfraz, Ali Amirkhosravi, Jamie M. Walker, et al. "Functional Consequences of Cellular Interactions with Heparin-PF4 Antibodies in Heparin-Induced Thrombocytopenia." Blood 104, no. 11 (2004): 3498. http://dx.doi.org/10.1182/blood.v104.11.3498.3498.

Full text
Abstract:
Abstract Heparin-induced thrombocytopenia (HIT) is a potentially devastating complication of heparin therapy. The condition is due to formation of antibodies to the heparin-platelet factor 4 (HPF4) complex that activate platelets and/or endothelial cells by binding to FcγIIa (CD32) receptors. It is not clear why only a sub-population of patients that form HPF4 antibodies also develops clinical HIT, and why only a fraction of those develop thrombosis. We hypothesized that some functionally active HPF4 antibodies (i.e. that activate platelets) may also activate leukocytes and endothelial cells b
APA, Harvard, Vancouver, ISO, and other styles
9

Sandoval-Sus, Jose D., Damien Mikael Hansra, Maureen Cioffi Lavina, et al. "Pulmonary blastoma: A clinicopathologic study of three cases." Journal of Clinical Oncology 31, no. 15_suppl (2013): e19140-e19140. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e19140.

Full text
Abstract:
e19140 Background: Pulmonary blastoma (PB) is a rare biphasic neoplasm representing 0.2-0.5% of pulmonary malignancies. Presentation ranges from asymptomatic to symptoms of advanced pulmonary tumors. Surgery is the preferred treatment with no consensus on the role of other adjuvant therapies. Methods: We report the clinicopathologic features of PB in 3 patients (pts). Retrospective review of medical records of pts diagnosed with PB at Jackson Memorial Hospital, Miami, FL since 2009. Staging performed using the 2009 AJCC system for NSCLC. Cases required pathological diagnosis before inclusion.
APA, Harvard, Vancouver, ISO, and other styles
10

Menapace, Bryan, Walter Jeske, Vicki Escalante, Erin Coglianese, Jeffrey Schwartz, and Jeanine M. Walenga. "Cellular Microparticles As Predictive Markers for Thrombosis and Other Clinical Events in Patients with Implanted Lvads." Blood 124, no. 21 (2014): 4995. http://dx.doi.org/10.1182/blood.v124.21.4995.4995.

Full text
Abstract:
Abstract Introduction: Since the implantation of left ventricular assist devices (LVAD) in heart failure patients has become more frequent, the need to prevent, predict, and treat the associated pathologies has become paramount. The most common complications, which include thrombosis, gastrointestinal bleeds, anemia, and hemolysis, are also the adverse events that carry a less than favorable prognosis. Current methods for predicting these conditions, i.e. elevated LDH or low hemoglobin levels, typically provide an alert, at most, days in advance. This can result in inadequate time to prevent t
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Cellules MIAMI"

1

Rmaidi, Assia. "Vecteurs synthétiques et approche mécano-biologique permettant d’optimiser l’utilisation des cellules souches en médecine régénérative." Thesis, Angers, 2019. http://www.theses.fr/2019ANGE0014.

Full text
Abstract:
Une approche de la médecine régénérative du système nerveux consiste à développer des substituts biologiques avec une fonction réparatrice en utilisant des cellules souches et des biomatériaux qui peuvent être recouverts des molécules de la matrice extracellulaire. Nous avons ainsi développé des microcarriers pharmacologiquements actifs, MPA. Ce sont des microsphères (MS) polymériques à base de PLGA, biodégradables et biocompatibles, recouvertes des molécules d’adhérence qui fournissent un support en 3-dimensions aux cellules. Les microcarriers ainsi associés aux cellules souches permettent, a
APA, Harvard, Vancouver, ISO, and other styles
2

Daviaud, Nicolas. "Développement de microcarriers pharmacologiquement actifs transportant des cellules souches pour le traitement de maladies neurodégénérativese." Angers, 2013. https://tel.archives-ouvertes.fr/tel-01080221/document.

Full text
Abstract:
L'association de cellules souches adultes à des vecteurs polymériques bioactifs est une approche prometteuse pour traiter les pathologies neurodégénératives comme la maladie de Parkinson ou la maladie de Huntington. Il a été précédemment démontré que la transplantation d'une sous population de cellules stromales mésenchymateuses, les cellules MIAMI, associées à des microcarriers pharmacologiquement actifs (MPA) enrobés de laminine et délivrant de la neurotrophine-3 (LM-MPA-NT3) permettait d'obtenir une réparation/protection de la voie nigrostriée. L'objectif de ce projet est de comprendre les
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Cellules MIAMI"

1

Wayne, Streilein J., ed. Advances in gene technology: Molecular biology of the immune system : proceedings of the Seventeenth Miami Winter Symposium, Miami, Florida, U.S.A., February 11-15, 1985. Cambridge University Press, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Miami Nature Biotechnology Winter Symposium (1999). Advances in gene technology: Signal transduction and theraoeutic strategies, February 6-10, 1999 ; proceedings of the 1999 Miami Nature Biotechnology Winter Symposium. Edited by Ahmad F. 1935-, Sylvester Comprehensive Cancer Center, and University Biochemistry and Molecular Biology Foundation. Oxford University Press, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Miami Bio/Technology Winter Symposia (1990). Advances in gene technology: The molecular biology of immune diseases and the immune response : proceedings of the 1990 Miami Bio/Technology Winter Symposia. IRL Press at Oxford University Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Cellules MIAMI"

1

Arai, T., and A. Mitsui. "Cellular Biochemical Activities and Induction of Synchronous Growth in a Unicellular Aerobic Nitrogen-Fixing Cyanobacterium, Synechococcus Sp. Strain Miami BG 043511." In Progress in Photosynthesis Research. Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-3535-8_154.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cellules MIAMI"

1

Rochman, Muhammad Iqbal, Vanlin Sathya, Norlen Nunez, et al. "A Comparison Study of Cellular Deployments in Chicago and Miami Using Apps on Smartphones." In ACM MobiCom '21: The 27th Annual International Conference on Mobile Computing and Networking. ACM, 2021. http://dx.doi.org/10.1145/3477086.3480843.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Neel, Benjamin G. "Abstract IA20: Analyzing the cellular basis for heterogeneity in serous ovarian carcinoma." In Abstracts: AACR Special Conference on Advances in Ovarian Cancer Research: From Concept to Clinic; September 18-21, 2013; Miami, FL. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1078-0432.ovca13-ia20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Molony, Ryan D., Sunyoung Jang, Adwait Oka та ін. "Abstract PR17: Targeted blockade of FcγRIIB on dendritic cells and macrophages enhances cellular activation and Fc-dependent immune responses". У Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 27-30, 2018; Miami Beach, FL. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm18-pr17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

De Martino, Mara, Mercedes Tkach, María F. Mercogliano, et al. "Abstract B25: Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 27-30, 2018; Miami Beach, FL. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm18-b25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Amara, Suha Naffar-Abu, Laura M. Selfors, Marit Krohn, et al. "Abstract PR09: Cellular heterogeneity of ovarian carcinoma cells and its impact on tumor behavior." In Abstracts: AACR Special Conference on Advances in Ovarian Cancer Research: From Concept to Clinic; September 18-21, 2013; Miami, FL. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1078-0432.ovca13-pr09.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Zavadova, Eva, Bohuslav Konopasek, Michal Vocka, et al. "Abstract B9: Abnormalities in cellular and humoral immunity in breast cancer patients resistant to endocrine therapy." In Abstracts: AACR Special Conference on Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances; December 2-5, 2012; Miami, FL. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tumimm2012-b9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Helfer, Brooke M., Anthony Balducci, Julie Urban та ін. "Abstract B44: Enabling in vivo visualization of cellular therapies in the clinic: Maturation of αDC1 data sets." У Abstracts: AACR Special Conference on Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances; December 2-5, 2012; Miami, FL. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tumimm2012-b44.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Chinn, Jason, Crystal Cummings, Felecia Wagener, et al. "Abstract B18: Combining selective toll-like receptor 9 (TLR9) agonists and GM-CSF activity for potentiating cellular activation in active cell immunotherapy (ACI)." In Abstracts: AACR Special Conference on Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances; December 2-5, 2012; Miami, FL. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tumimm2012-b18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!